Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children

This study has been completed.
Sponsor:
Collaborator:
Procter and Gamble
Information provided by:
Universidad Autonoma de Queretaro
ClinicalTrials.gov Identifier:
NCT00822380
First received: January 13, 2009
Last updated: NA
Last verified: January 2009
History: No changes posted
  Purpose

Anemia continues to be a major public health problem in many regions of the world and it is still not clear which strategy is more effective in children population in terms of adherence and efficacy. The objective was to evaluate the efficacy and acceptance of several strategies that have been recently recommended to treat anemia on anemic children (6 to 43 mo):Iron supplement, iron+folic acid supplement, a multiple micronutrients supplement a micronutrient fortified complementary food in the form of porridge powder or zinc+iron+ascorbic acid fortified water.


Condition Intervention
Anemia
Dietary Supplement: Iron
Dietary Supplement: Multiple micronutrients supplement
Dietary Supplement: micronutrient fortified porridge powder
Dietary Supplement: Iron and ascorbic acid fortified water
Dietary Supplement: Iron plus folic acid supplement

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children: A Randomized Clinical Trial

Resource links provided by NLM:


Further study details as provided by Universidad Autonoma de Queretaro:

Enrollment: 680
Study Start Date: March 2003
Study Completion Date: November 2004
Primary Completion Date: November 2003 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Anemic children Dietary Supplement: Iron
Daily 20mg of ferrous sulfate in liquid solution during 4 months
Dietary Supplement: Multiple micronutrients supplement
Daily supplement with 10mg of iron plus several micronutrients following a formula designed to treat anemia in indigenous population in Mexico. During 4 months.
Dietary Supplement: micronutrient fortified porridge powder
Daily powdered complementary food designed for a national program in Mexico with 10mg of iron plus several micronutrients during 4 months
Dietary Supplement: Iron and ascorbic acid fortified water
A drink water product fortified with 6.7 mg ofiron, zinc and ascorbic acid. This product was asked to be used for drinking and for cooking for the child during 4 months.
Dietary Supplement: Iron plus folic acid supplement
Daily liquid solution following the daily iron (12.5mg)and folic acid recommendation of UNICEF to treat anemia during 4 months

  Eligibility

Ages Eligible for Study:   6 Months to 42 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Hemoglobin less than 11.7g/dL and above 7.0g/dL

Exclusion Criteria:

  • Breastfeeding
  • Chronic gastroenteritis
  • Any other severe illness
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided by Universidad Autonoma de Queretaro

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Dr Jorge Luis Rosado Loria, Universidad Autonoma de Querétaro
ClinicalTrials.gov Identifier: NCT00822380     History of Changes
Other Study ID Numbers: FNN2002-07
Study First Received: January 13, 2009
Last Updated: January 13, 2009
Health Authority: Mexico: Ministry of Health

Keywords provided by Universidad Autonoma de Queretaro:
Anemia
Iron
Children
Micronutrients

Additional relevant MeSH terms:
Anemia
Hematologic Diseases
Ascorbic Acid
Folic Acid
Iron
Micronutrients
Vitamin B Complex
Trace Elements
Antioxidants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protective Agents
Physiological Effects of Drugs
Vitamins
Growth Substances
Hematinics
Hematologic Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on April 17, 2014